COPD Clinical Trials near Philadelphia, PA
25 studies for COPD are recruiting at 38 sites within 50 miles of Philadelphia, Pennsylvania, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all COPD trials in the US or all trials near Philadelphia.
Recruiting now
COPD studies enrolling near Philadelphia
- myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
NCT05204888
- Interventional
- Ages 30 years and older
- Sex: All
Nearest sites: Jeanes Hospital (Philadelphia, PA); Temple University (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
NCT06122077
- Observational
- Ages 50 years and older
- Sex: All
Nearest sites: Temple University (Philadelphia, PA); Inspira Medical Center (Mullica Hill, NJ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
NCT06283966
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest sites: Research Site (Philadelphia, PA); Research Site (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
NCT06883305
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest sites: Research Site (Philadelphia, PA); Research Site (Sewell, NJ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
NCT06961214
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest sites: GSK Investigational Site (Philadelphia, PA); GSK Investigational Site (Moorestown, NJ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
NCT06035120
- Interventional
- Ages 40 to 80 years
- Sex: All
Nearest sites: Penn Medicine (Philadelphia, PA); Temple University (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
NCT07082738
- Phase 2
- Ages 40 years and older
- Sex: All
Nearest sites: Research Site (Philadelphia, PA); Research Site (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- COPD Exacerbation Follow Up
NCT07118306
- Observational
- Ages 40 years and older
- Sex: All
Nearest sites: Thomas Jefferson University (Philadelphia, PA); Cooper University Health Care (Cherry Hill, NJ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- STRIVE Post-Market Registry Study
NCT04302272
- Observational
- Ages 18 years and older
- Sex: All
Nearest site: Temple University (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- SPIROMICS Study of Early COPD Progression (SOURCE)
NCT05033990
- Observational
- Ages 30 to 55 years
- Sex: All
- Accepts healthy volunteers
Nearest site: Temple University (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Feasibility of Semaglutide in Advanced Lung Disease
NCT05746039
- Phase 1/2
- Ages 18 to 80 years
- Sex: All
Nearest site: University of Pennsylvania Perelman School of Medicine (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Supporting Evidence-based Responses to Emotional Needs in Emphysema
NCT06600126
- Interventional
- Ages 18 years and older
- Sex: All
Nearest site: University of Pennsylvania (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
NCT06891755
- Interventional
- Ages 40 to 84 years
- Sex: All
Nearest site: Temple University (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Temple Health Chest Initiative (THCI 2.0)
NCT06933758
- Observational
- Ages 50 to 80 years
- Sex: All
- Accepts healthy volunteers
Nearest site: Temple University Of the Commonwealth System of Higher Education (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry
NCT06974981
- Observational
- Ages 50 to 80 years
- Sex: All
Nearest site: Thomas Jefferson University (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
NCT07051707
- Interventional
- Ages 40 to 80 years
- Sex: All
Nearest site: Temple University - Temple Lung Center (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
NCT07059091
- Phase 2
- Ages 40 years and older
- Sex: All
Nearest site: Temple University (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
NCT07190209
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest site: Temple University Hospital- Site Number : 8400059 (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
NCT07222410
- Interventional
- Ages 22 years and older
- Sex: All
Nearest site: Temple University Hospital (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
NCT07684820
- Phase 2
- Ages 40 to 85 years
- Sex: All
Nearest site: DM Clinical Research - Philadelphia (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
NCT07190222
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest site: Suburban Research Associates - Media- Site Number : 8400143 (Media, PA)
- Distance to nearest recruiting site
- ~12 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
NCT07177339
- Phase 3
- Ages 40 to 75 years
- Sex: All
Nearest site: GSK Investigational Site (West Chester, PA)
- Distance to nearest recruiting site
- ~24 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
NCT06878261
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest site: Research Site (Wilmington, DE)
- Distance to nearest recruiting site
- ~25 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
NCT06959095
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest site: GSK Investigational Site (Wilmington, DE)
- Distance to nearest recruiting site
- ~25 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Multi-Center Clean Air Randomized Controlled Trial in COPD
NCT06376994
- Phase 3
- Ages 40 years and older
- Sex: All
Nearest site: Reading Hospital (West Reading, PA)
- Distance to nearest recruiting site
- ~49 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining a COPD clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.